effects [qlco]
Raloxifene [orch, phsu]
bone metabolism [ortf]
Serum lipids NOS [lbpr]
postmenopausal [tmco]
Women [popg]
chronic [tmco]
Haemodialysis [topp]
Background [cnce]
Premature [tmco]
Amenorrhea [dsyn]
lack [qlco]
Hormone replacement therapy [topp]
Menopause [phsf]
Frequently [tmco]
Reported [inpr]
Women [popg]
Dialysis [npop]
Renal Osteodystrophy [dsyn]
postmenopausal [tmco]
Women [popg]
Dialysis [npop]
Osteoporosis [dsyn]
Addition [ftcn]
Patients [podg]
High Risk [qlco]
Hyperlipidaemia [dsyn]
Arteriosclerosis [dsyn]
Subsequent [tmco]
coronary heart disease [dsyn]
Stroke [dsyn]
Recent [tmco]
Evidence [ftcn]
Suggest [idcn]
Hormone replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
Several [qnco]
effects [qlco]
Serious [qlco]
Risks [qlco]
Great [qnco]
Effort [orgf]
Make [ftcn]
To [qlco]
therapeutic alternative [inpr]
Benefits [qnco]
Estrogen [horm, phsu, strd]
Brain [bpoc]
Bone [bpoc]
adverse effects [ftcn]
Breast [bpoc]
Endometrium [bpoc]
Present [qnco]
Study [mnob]
Evaluated [ftcn]
Effect [qlco]
Raloxifene [orch, phsu]
Selective Estrogen Receptor Modulator [horm, phsu]
bone metabolism [ortf]
Serum lipids NOS [lbpr]
postmenopausal [tmco]
Women [popg]
chronic [tmco]
Haemodialysis [topp]
Methods [inpr]
Performed [ftcn]
prospective [resa]
Blind [resa]
placebo-controlled [resa]
randomized [resa]
Study [mnob]
postmenopausal [tmco]
Women [popg]
chronic [tmco]
Haemodialysis [topp]
Proven [qlco]
Severe osteopenia [fndg]
Osteoporosis [dsyn]
bone densitometry [diap]
Select [acty]
write [ocdi]
Informed Consent [rnlw]
Patients [podg]
randomized [resa]
Two [qnco]
Group [idcn]
Women [popg]
placebo [topp]
Women [popg]
study drug [resa]
Raloxifene Hydrochloride [orch, phsu]
Dose [qnco]
mg day [qnco]
Patients [podg]
Performed [ftcn]
baseline [bodm]
Bone Mineral Density [clna]
Analysis [lbpr]
simultaneously [tmco]
Evaluated [ftcn]
Different [qlco]
Biochemical [ftcn]
Parameters [fndg]
Serum lipids NOS [lbpr]
Low density lipoprotein [aapp, bacs, lipd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglycerides [bacs, lipd]
Serum Markers [qlco]
Bone Resorption [ortf]
pyridinoline [aapp, bacs]
crosslinks [npop]
baseline [bodm]
Bone Mineral Density [clna]
therapy [ftcn]
bone markers [medd]
Resorption [orgf]
Result [ftcn]
Raloxifene [orch, phsu]
therapy [ftcn]
Lumbar spine [bpoc]
baseline [bodm]
Bone Mineral Density [clna]
Trabecular bone [tisu]
Improved [qlco]
Femoral Neck [bpoc]
baseline [bodm]
Bone Mineral Density [clna]
Cortical bone [bpoc]
Not [ftcn]
Change [ftcn]
baseline [bodm]
Bone Mineral Density [clna]
Observed [ftcn]
Trabecula [tisu]
Cortical [bpoc]
Sites [spco]
placebo [topp]
Group [idcn]
Serum [bdsu]
pyridinoline [aapp, bacs]
Levels [qlco]
Show [inpr]
Decrease [qlco]
months [tmco]
Raloxifene [orch, phsu]
Low density lipoprotein [aapp, bacs, lipd]
Cholesterol [bacs, strd]
Decreased [qnco]
Raloxifene [orch, phsu]
Group [idcn]
serum triglycerides [lbpr]
Total Cholesterol [lbpr]
High Density Lipoprotein Cholesterol [bacs, lipd]
side effects [ftcn]
Observed [ftcn]
Raloxifene [orch, phsu]
Group [idcn]
Conclusion [idcn]
Study [mnob]
One [qnco]
Raloxifene [orch, phsu]
postmenopausal [tmco]
Women [popg]
Haemodialysis [topp]
Increase [ftcn]
Trabecula [tisu]
baseline [bodm]
Bone Mineral Density [clna]
Decrease [qlco]
bone markers [medd]
Resorption [orgf]
Cholesterol, LDL [bacs, strd]
Values [qlco]
Suggest [idcn]
SERMs [horm, phsu]
therapeutic alternative [inpr]
bone metabolism [ortf]
Control [grup]
Hyperlipidaemia [dsyn]
Patients [podg]
Possible [qlco]
Long-Term Effects [phpr]
Raloxifene [orch, phsu]
To [qlco]
